Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Income Statement [Abstract]
Revenue	$ 2,302	$ 3,411
Operating expenses:
Research and development	15,565	20,657
General and administrative	8,158	7,084
Total operating expenses	23,723	27,741
Loss from operations	(21,421)	(24,330)
Other (expense) income:
Change in fair value of warrant liability	102	(337)
Change in fair value of term loan	(1,530)	(1,053)
Interest income	1,326	1,693
Interest expense	(19)	(29)
Other income (expense)	13	(5)
Total other (expense) income, net	(108)	269
Net loss	$ (21,529)	$ (24,061)
Net loss per common share, basic	$ (0.08)	$ (0.1)
Net loss per common share, diluted	$ (0.08)	$ (0.1)
Weighted average common shares outstanding, basic	269,306,331	231,249,344
Weighted average common shares outstanding, diluted	269,306,331	231,249,344